First-Trimester Trimethoprim Linked to Increased Birth Defects in Large US Study
First-Trimester Trimethoprim Linked to Increased Birth Defects in Large US Study

First-Trimester Trimethoprim Linked to Increased Birth Defects in Large US Study

News summary

Recent large-scale studies have highlighted significant risks associated with the use of the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX) during the first trimester of pregnancy for treating urinary tract infections (UTIs). Research involving over 70,000 pregnancies found that TMP-SMX is linked to an increased risk of congenital malformations, including severe cardiac defects and cleft lip and palate, compared to beta-lactam antibiotics. Although UTIs are common and pose serious risks if untreated, the choice of antibiotic is critical, as trimethoprim may interfere with folic acid metabolism, essential for fetal development. Conversely, nitrofurantoin, another commonly prescribed antibiotic for UTIs, did not show an elevated risk of birth defects, supporting its relative safety in early pregnancy. Experts emphasize the importance of selecting appropriate antibiotics at the lowest effective dose and shortest duration, especially during organogenesis, to minimize fetal risks. These findings align with current recommendations from the American College of Obstetricians and Gynecologists to avoid TMP-SMX and nitrofurantoin in the first trimester when possible, despite their frequent use.

Story Coverage
Bias Distribution
100% Right
Information Sources
605a98c4-d25e-430b-86c1-9232b14faa6b
Right 100%
Coverage Details
Total News Sources
1
Left
0
Center
0
Right
1
Unrated
0
Last Updated
22 hours ago
Bias Distribution
100% Right
Related News
Daily Index

Negative

25Serious

Neutral

Optimistic

Positive

Ask VT AI
Story Coverage

Related Topics

Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Related News
Recommended News